/Companies

Lunair Medical

Minneapolis, US · Founded 2023 · Delaware corporation · 1 known investors

Find your way into Lunair Medical

Sign up to see every warm intro you have to Lunair Medical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Lunair Medical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.

Founders & leadership

MCMark Christopherson
Mark ChristophersonChief Executive OfficerMark Christopherson is CEO of Lunair Medical and previously served as CEO of Cryosa and co-founding executive at Inspire Medical Systems, where he led development of an implantable neurostimulation therapy for obstructive sleep apnea. He holds a master's degree in Electrical Engineering from the University of Minnesota and a bachelor's degree in Physics from Bethel University.
HLHoward Levin
Howard LevinNamed on SEC filing

Board

PLPaul LaViolette
Paul LaVioletteBoard directorManaging Partner at SV Health Investors
DNDavid Neustaedter
David NeustaedterBoard MemberDirector at Reprieve Cardiovascular
MHMichael Hurley
Michael HurleyBoard director

Investors · 1

Reported raises · per SEC filings

Form D private placements

$7.5M disclosed across 1 round · 2025

▶$7.5MraisedSep 2025 · 3 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Paul LaVioletteDirector
  • Howard LevinDirector
  • David NeustaedterDirector
  • Michael HurleyDirector
  • Mark ChristophersonExecutive Officer, Director
Offering amount
$12.5M
Amount sold
$7.5M
First sale
Aug 2025
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 5

Companies working in the same space as Lunair Medical.

Frequently asked questions

What does Lunair Medical do?
Lunair Medical develops an implantable closed-loop system that senses respiration and stimulates the phrenic nerve to treat moderate-to-severe sleep apnea, avoiding masks, mouthpieces, and wearables. The device, currently under investigation, includes a stimulation lead, pulse generator, and titration lead to support automated therapy adjustment and patient management.
Who are Lunair Medical's investors?
Lunair Medical's investors include SV Health Investors.
How much funding has Lunair Medical raised?
Lunair Medical has disclosed $7.5M raised across 1 round.
Where is Lunair Medical headquartered?
Lunair Medical is headquartered in Minneapolis, US.